Axis Spine Technologies Ltd (AST) has raised a further £1.06m in funding round

Nov 25, 2021 |

Axis Spine Technologies Ltd has raised £1.06m in a funding round with follow-on investments from Mercia and ACF Investors, as well as a syndicate of angel investors.

Axis is developing the next generation of Anterior Spinal Implant technology.  Axis’s modular fusion devices are inserted with less force than conventional implants to help reduce the risks of structural damage to the vertebral bones which may lead to implant subsidence, which Axis believes is an under-reported and recognized complication.  The modular technology enables surgeons to achieve corrections not possible with other devices and thus aiding the re-balancing of the spine. This is done with fewer part numbers compared to conventional systems resulting in optimized health economics.

read more…

MedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors

Feb 19, 2021 |

Spinal implant startup is the first to receive funding from ACF Investors’ Delta Fund, thanks to the backing of expert medtech angel investor

27, January 2021 – Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS funds. Mercia was the first investor when Axis was founded by Jon Acros in 2017.  This is the first investment from ACF Investors’ new Delta Fund, a fast-track investment fund designed for high-potential UK businesses that have been backed by a syndicate of angel investors with deep sector knowledge. Axis is developing the next generation of Anterior Spinal Implant technology which provides surgeons with increased correction and alignment options. Its modular devices are inserted with less force than conventional implants to reduce the risks of structural damage which can lead to subsidence, an under-reported and recognised complication. read more…

Orthopedics This Week: Axis Spine’s Modular Interbody Device Cleared

Jul 2, 2020 |

Axis Spine Technologies, Ltd. was granted FDA 510(k) clearance on May 20, 2020 for its first device, a modular interbody fusion device for anterior lumbar interbody fusion (ALIF), the Axis-ALIF. The device was cleared just over three months after submission for single and contiguous 2-level use.

The company plans to have the device available for surgery by August or September of this year. Axis Spine, based in St. Albans, UK near London, decided to forego CE marking preferring to first enter the U.S. market. There, the company hopes to generate clinical data to support future clearances.

Read full article on Orthopedics This Week

Fundraising March 2020

Mar 21, 2020 |

Axis Spine Technologies – which is helping to develop the next generation of spinal implant technology – received £830,000 from investors Mercia Asset Management. The funding round was signed off despite the coronavirus pandemic, which has left many start-ups fearful about survival.

Axis founder Jonathan Arcos said: ‘The current trading environment is very challenging, but this investment will help take us to the next level. Thankfully we were at quite an advanced stage when the lockdown measures were first brought in. We are delighted to get it over the line.’ read more…